Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prevenar 13 in Sepsis Survivors
NCT03565159Phase 4Completed
- Sponsor
- Guy's and St Thomas' NHS Foundation Trust
- Start
- Aug 2018
- Primary completion
- Aug 2023
- Modality
- Split/Subunit Vaccines
- Countries
- 1
01
Overview
A Phase 4 trial of pneumococcal 13-valent conjugate vaccine in Infection, sponsored by Guy's and St Thomas' NHS Foundation Trust. Started Aug 2018; status: completed.
02
Drugs
pneumococcal 13-valent conjugate vaccine
03
Conditions
Infection
Beyond the preview
Go deeper on NCT03565159.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03565159.